Wednesday, August 10, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

USAMRIID Providing Laboratory Support to Ebola Outbreak

by Global Biodefense Staff
July 15, 2014

Analysis of clinical samples from suspected Lassa fever cases in Sierra Leone showed that about two-thirds of the patients had been exposed to other emerging diseases, and nearly nine percent tested positive for Ebola virus.

The findings, published in this month’s edition of Emerging Infectious Diseases, demonstrates that Ebola virus has been circulating in the region since at least 2006—well before the current outbreak.

First author Randal J. Schoepp, Ph.D., recently returned from Liberia and Sierra Leone, where he spent six weeks helping to set up an Ebola testing laboratory and training local personnel to run diagnostic tests on suspected Ebola hemorrhagic fever clinical samples. He is part of a team from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) that has been providing assistance to the Ebola outbreak in West Africa since March.

Three other USAMRIID personnel also have been involved in this ongoing effort: Wes Carter, who traveled with Schoepp to Liberia; Aileen O’Hearn, Ph.D., who recently returned from providing laboratory support to Kenema Government Hospital (KGH) in Sierra Leone; and Matthew Voorhees, who is currently onsite at KGH.

USAMRIID has been working in the region since 2006, when it began a collaborative project to develop and refine diagnostic tests for the Lassa fever virus endemic to Sierra Leone, Liberia and Guinea. As those assays have matured, the scientists have begun to optimize additional tests for a number of emerging diseases.

Because the team was working on disease identification and diagnostics, and had pre-positioned assays in the region, said Schoepp, “We had people on hand who were already evaluating samples and volunteered to start testing right away when the current Ebola outbreak started.”

According to the publication’s authors, between 500 and 700 samples are submitted each year to the KGH Lassa Diagnostic Laboratory in Sierra Leone. Generally, only 30 to 40 percent of the samples test positive for Lassa fever, so the aim of this study was to determine which other viruses had been causing serious illnesses in the region.

Using assays developed at USAMRIID that detect the presence of IgM, an early protein produced by the body to ward off infection, the research team found evidence of dengue fever, West Nile, yellow fever, Rift Valley fever, chikungunya, Ebola, and Marburg viruses in the samples collected between 2006 and 2008.

In addition, of the samples that tested positive for Ebola, the vast majority reacted to the Zaire strain, which was unexpected, according to the authors.

“Prior to the current outbreak, only one case of Ebola had ever been officially reported in this region, and it was from the Ivory Coast strain,” said Schoepp. “We were surprised to see that Zaire—or a variant of Zaire—was causing infection in West Africa several years ago.”

The laboratory testing site in Kenema is supported by the Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System. In collaboration with the host country, the site enables collection of samples that can be used in research toward new medical countermeasures, and allows USAMRIID to evaluate the performance of previously developed laboratory tests using samples collected on-site. The Institute hopes to eventually obtain viral isolates for medical countermeasure development and receive data on the performance of the diagnostic assays.

In addition to providing laboratory testing and training support for the current outbreak, USAMRIID has provided more than 10,000 Ebola assays to support laboratory capabilities in Sierra Leone and Liberia. The Institute also supplied personal protective equipment to Metabiota Inc., a non-government organization (NGO) involved in the testing.

Other contributors to the work include the Department of Defense Joint Program Executive Office-Critical Reagents Program, the Defense Threat Reduction Agency (DTRA) Cooperative Biological Engagement Program, and the DTRA Joint Science and Technology Office.

COL Erin P. Edgar, commander of USAMRIID, called the project “a great example of medical diplomacy at work.”

“This collaboration allows USAMRIID to bring our expertise to bear in responding to an international health crisis,” he said. “In addition, it enables us to test the medical diagnostics that we develop in a real-world setting where these diseases naturally occur.”

Read the study at Emerging Infectious Diseases : Undiagnosed acute viral febrile illnesses, Sierra Leone.

Source: US Army Medical Research Institute of Infectious Diseases, adapted.

Tags: Cooperative Threat ReductionDefense Threat Reduction AgencyEbolaEmerging ThreatsLassa FeverUSAMRIID

Related Posts

Does the Current Monkeypox Outbreak Qualify as an Epidemic, PHEIC, or Pandemic?
Outbreak News

Does the Current Monkeypox Outbreak Qualify as an Epidemic, PHEIC, or Pandemic?

July 15, 2022
Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control
Medical Countermeasures

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Load More

Latest News

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

Bacteria That Causes Melioidosis Confirmed in Environmental Samples in Mississippi Gulf Coast

July 27, 2022
Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

Monkeypox Transmission: Virus Detected in Saliva, Bodily Fluids

July 17, 2022
Influenza Transmission Spikes During Social Gatherings

New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections

July 17, 2022
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19

July 17, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC